Skip to main content
Livermore
Livermore
ZHEN

Alliancebernstein L.P.

SEC CIK
0001109448
Latest filing
Aug 14, 2026

VKTX holding history

Viking Therapeutics, Inc. in every 13F filed by Alliancebernstein L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings

Shares (Q2 2026)
34,550
Value
$1.12M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of VKTX by Alliancebernstein L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202634,550$1.12M<0.1%+7,881+29.6%AddedHolders
Q1 202626,669$938.2K<0.1%−2,815−9.5%ReducedHolders
Q4 202529,484$1.04M<0.1%+2,616+9.7%AddedHolders
Q3 202526,868$706.1K<0.1%+1,108+4.3%AddedHolders
Q2 202525,760$682.6K<0.1%−1,013,657−97.5%ReducedHolders
Q1 20251,039,417$25.1M<0.1%−75,651−6.8%ReducedHolders
Q4 20241,115,068$44.9M<0.1%+81,183+7.9%AddedHolders
Q3 20241,033,885$65.5M<0.1%−207,240−16.7%ReducedHolders
Q2 20241,241,125$65.8M<0.1%−319,753−20.5%ReducedHolders
Q1 20241,560,878$128.0M<0.1%−2,113,057−57.5%ReducedHolders
Q4 20233,673,935$68.4M<0.1%+123,861+3.5%AddedHolders
Q3 20233,550,074$39.3M<0.1%+588,513+19.9%AddedHolders
Q2 20232,961,561$48.0M<0.1%+2,947,905+21,586.9%AddedHolders
Q1 202313,656$227.4K<0.1%+13,656NewHolders
Q2 20220$00.0%−79,600−100.0%Sold outHolders
Q1 202279,600$239.0K<0.1%+200+0.3%AddedHolders
Q4 202179,400$365.0K<0.1%00.0%UnchangedHolders
Q3 202179,400$499.0K<0.1%00.0%UnchangedHolders
Q2 202179,400$476.0K<0.1%+14,400+22.2%AddedHolders
Q1 202165,000$411.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.